Atlas Trials

A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients

Clinical trial NCT02000609 · COMPLETED

Trial details

NCT number
NCT02000609
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COPD
Start date
2013-12-01
Primary completion
2014-04-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.